(Q47861350)

6 February 2018

title

Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma. (English)

1 reference

6 February 2018

author

Joachim Schultze

13

1 reference

6 February 2018

Paul G. Richardson

6

Paul G Richardson

1 reference

6 February 2018

Kenneth C. Anderson

11

Kenneth C Anderson

1 reference

6 February 2018

Nikhil V Munshi

10

Nikhil C Munshi

1 reference

6 February 2018

Robert Schlossman

7

Robert L Schlossman

1 reference

6 February 2018

Lee M. Nadler

12

Lee M Nadler

1 reference

6 February 2018

author name string

Britta Maecker

1

1 reference

6 February 2018

Karen S Anderson

2

1 reference

6 February 2018

Michael S von Bergwelt-Baildon

3

1 reference

6 February 2018

Edie Weller

4

1 reference

6 February 2018

Robert H Vonderheide

5

1 reference

6 February 2018

Isaura A Menezes

8

1 reference

6 February 2018

Zhinan Xia

9

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 February 2018

British Journal of Haematology

published in

1 reference

6 February 2018

volume

121

1 reference

6 February 2018

page(s)

842-848

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Distribution of T-cell signalling molecules in human myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

Deregulated cytokine network and defective Th1 immune response in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04375.X

10.1046/J.1365-2141.2003.04375.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

12786794

1 reference

6 February 2018